Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Closing the gap: Genetic profiling of B-cell lymphomas using integrative whole-exome and whole-transcriptome sequencing

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAditya SharmaPKPrabhjot Kaur

Discussion

Loading...

Member takes

Overview

Analysis shows 79% clinically relevant variants in B cell lymphomas, suggesting whole-exome sequencing may improve personalized therapy outcomes.

Key Points

  • Identified 79% clinically relevant variants in 38 B cell lymphoma specimens, enhancing treatment precision.
  • Genetic profiling revealed significant copy number and pathogenic variant alterations across lymphoma subtypes.
  • Next-generation sequencing methods facilitated the detection of diverse genomic variations and their clinical implications.
  • Genomic data integration supports the development of targeted therapies and molecularly-stratified trials for B-cell lymphoma.

Cite This Study

Sharma et al. (2025) studied this question.

synapsesocial.com/papers/69362f444fa91c937236d56ehttps://doi.org/10.1182/blood-2025-7067
View Full Paper
Ask AI
Bookmark
Share